Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2023 pubmed

Does kisspeptin exert a local modulatory effect on bovine ovarian steroidogenesis?

Mattar. Dareen D; Cheewasopit. Warakorn W; Samir. Moafaq M; Knight. Philip G PG

Key Findings

  • KISS1 and its receptor KISS1R are expressed in bovine granulosa, theca, and luteal cells.
  • Treating cultured ovarian cells with kisspeptin-10 (10⁻¹⁰ M) or a kisspeptin antagonist had no effect on estradiol, progesterone, or androstenedione secretion.
  • Cell viability was unchanged by kisspeptin-10 or the antagonist under both luteinizing and non‑luteinizing conditions.

Practical Outcomes

  • For biohackers hoping to use kisspeptin-10 to boost fertility or modulate ovarian hormones, this study suggests there’s no direct benefit from local ovarian administration. Kisspeptin’s known role remains central (hypothalamic) rather than peripheral, so protocols should focus on its systemic effects rather than targeting the ovary.

Summary

Researchers looked at whether kisspeptin-10 can directly change hormone production in cow ovarian cells. They found the peptide and its receptor are present, but adding kisspeptin or a blocker didn’t change steroid hormone levels or cell survival. So, kisspeptin doesn’t seem to act locally in the ovary to affect hormone output.

Abstract

Kisspeptin, a hypothalamic neuropeptide encoded by the KISS1 gene, has a pivotal role in promoting GnRH secretion in mammals. Kisspeptin and its receptor (KISS1R) are also expressed in certain peripheral tissues including gonads, suggesting intra-gonadal roles. Such actions at the level of the bovine ovary have not been explored previously. The current aims were to determine whether KISS1 and its receptor (KISS1R) are expressed in the bovine ovary and whether kisspeptin or a kisspeptin antagonist can modulate ovarian steroid production by cultured ovarian cells. Granulosa (GC) and theca interna (TC) were collected from antral follicles (3-18 mm) categorized into five class sizes. Early, mid and regressing corpora lutea (CL) were also collected for RT-qPCR analysis of KISS1 and KISS1R expression. Bovine TC and GC cultured under both non-luteinizing (serum-free) and luteinizing (serum-supplemented) conditions were treated for 4 days with kisspeptin-10 (10-10-10-6M) or kisspeptin antagonist (p234; 10-10-10-6M), alone and in combination with either FSH (GC), LH (TC) or forskolin (luteinized GC/TC). Steroid secretion (GC: oestradiol, progesterone; TC: androstenedione, progesterone; luteinized GC/TC: progesterone) was measured by ELISA and viable cell number determined by neutral red uptake assay. KISS1 and KISS1R transcripts were detected in TC, GC and CL with significant differences between follicle categories and CL stages. However, neither kisspeptin-10 nor kisspeptin antagonist affected steroid secretion or viable cell number in any of the four ovarian cell culture models. As such, the hypothesis that kisspeptin has a direct intra-ovarian role to modulate follicular or luteal steroidogenesis, or cell proliferation/survival, is not supported.

Study Information

Provider

pubmed

Year

2023

Date

2023-02-01T00:00:00.000Z

DOI

10.1530/raf-22-0088